Table:
Nanoagents	Activity	Ref.
Liposomes	Anticlotting inhibitors (PPACK) against acute thrombosis	[44]
Perfluorocarbon nanoparticles	Inhibitors (PPACK) of clot-bound thrombin	[46]
Polymeric nanocarriers	Enoxaparin for antithrombotic activity	[42]
Dendrimers	Enoxaparin for attenuation of thrombi formation	[47]
Magnetic nanoparticles	Conjugation agents along with urokinase for thrombolytic activity	[48]
Iron oxide nanoparticles	Conjugation agents along with tissue plasminogen activator for thrombolysis	[49]

Interpret the diagram as Markdown format.

| Nanoagents | Activity | Ref. | 
 | --- | --- | --- | 
 | Liposomes | Anticlotting inhibitors (PPACK) against acute thrombosis | [44] | 
 | Perfluorocarbon nanoparticles | Inhibitors (PPACK) of clot-bound thrombin | [46] | 
 | Polymeric nanocarriers | Enoxaparin for antithrombotic activity | [42] | 
 | Dendrimers | Enoxaparin for attenuation of thrombi formation | [47] | 
 | Magnetic nanoparticles | Conjugation agents along with urokinase for thrombolytic activity | [48] | 
 | Iron oxide nanoparticles | Conjugation agents along with tissue plasminogen activator for thrombolysis | [49] |